genotoxicity
Success and Accuracy in Genotoxicity and Carcinogenicity Testing: An FDA Perspective
September 21 by Pharma IQDr. Timothy Robison, Pharmacology/Toxicology Reviewer at the US Food and Drug Administration/CDER, joins Helen Winsor from Pharma IQ, to share the latest insights into achieving successful characteris...
Using Genotoxicity Tests to Push Drug Development Forward
September 14 by Pharma IQWhen it comes to the production of quality drugs and medicines, safety is arguably the fundamental concern of pharmaceutical companies based across the globe. So many of the regulatory standards and...
How to Identify and Control Genotoxic Impurities
August 08 by Pharma IQDr. Andrew Teasdale, Senior QA Executive at AstraZeneca, joins Helen Winsor from Pharma IQ, to discuss genotoxicity and carcinogenicity testing. He begins by summing up the challenges that exist with...
